Xilio Development Correlations
| XLO Stock | USD 0.78 0.01 1.27% |
The current 90-days correlation between Xilio Development and Connect Biopharma Holdings is -0.08 (i.e., Good diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Xilio Development moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Xilio Development moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
Xilio |
Moving against Xilio Stock
| 0.35 | AXDX | Accelerate Diagnostics Earnings Call This Week | PairCorr |
| 0.38 | SWZNF | Schweizerische Nationalbank | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Xilio Stock performing well and Xilio Development Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Xilio Development's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| CNTB | 3.47 | (0.18) | 0.00 | (0.28) | 0.00 | 7.59 | 29.84 | |||
| TYRA | 2.62 | (0.35) | 0.00 | (0.39) | 0.00 | 7.08 | 15.45 | |||
| RAPT | 3.54 | (0.31) | 0.00 | (0.42) | 0.00 | 9.01 | 16.99 | |||
| MLYS | 4.46 | 0.68 | 0.17 | (0.50) | 4.25 | 10.04 | 50.53 | |||
| EWTX | 2.92 | (0.07) | 0.00 | (0.12) | 0.00 | 5.32 | 26.44 | |||
| IKNA | 1.90 | (0.30) | 0.00 | (3.17) | 0.00 | 4.58 | 8.93 | |||
| DSGN | 4.21 | (0.08) | 0.00 | (0.18) | 0.00 | 9.45 | 26.51 | |||
| ELYM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| ANEB | 5.30 | 0.81 | 0.13 | 0.41 | 5.26 | 15.25 | 40.87 |
Xilio Development Corporate Management
| Kevin Brennan | Senior Accounting | Profile | |
| Martin MD | Pres RD | Profile | |
| Scott Coleman | Chief Officer | Profile | |
| Uli Bialucha | Chief Officer | Profile | |
| Bill Avery | VP Devel | Profile | |
| Caroline Hensley | Chief Officer | Profile |